baclofen has been researched along with Adverse Drug Event in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Syndromes include adrenergic "fever," anticholinergic "fever," antidopaminergic "fever," serotonin syndrome, malignant hyperthermia, uncoupling of oxidative phosphorylation, and withdrawal from baclofen." | 4.86 | Adverse drug reactions resulting in hyperthermia in the intensive care unit. ( McAllen, KJ; Schwartz, DR, 2010) |
| "Drug-induced seizures are in view of a constantly ageing population and increasingly frequent polypharmacotherapy an increasing problem in daily routine praxis." | 2.49 | [Drug-induced seizures]. ( Block, F; Dafotakis, M, 2013) |
| "This manifested as tetany in the hands in the form of bilateral carpopedal spasm." | 1.72 | Hypercalcaemia to hypocalcaemia: tetany as a side effect of intravenous bisphosphonate treatment. ( Bounds, L; McGrath, F; Taubert, M, 2022) |
| " We compared the informativity concerning the patient, treatment, seriousness and expectedness of adverse events described on these posts, with similar information coded in case reports from the French pharmacovigilance database (FPVD)." | 1.51 | [Informativity of French web forums for the evaluation of side effects of baclofen]. ( Bousquet, C; Karapetiantz, P; Lillo-Le Louët, A, 2019) |
| "Case note review of 278 children with dystonia referred to our service." | 1.43 | Medication use in childhood dystonia. ( Kaminska, M; Lin, JP; Lumsden, DE; Tomlin, S, 2016) |
| "To assess the frequency and types of adverse events (AEs) related to intrathecal baclofen (ITB) therapy in adults, and associated risk factors." | 1.40 | Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults. ( Bensmail, D; Borrini, L; Hugeron, C; Jourdan, C; Rech, C; Thiebaut, JB, 2014) |
| "5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, EJ | 1 |
| Kruhlak, NL | 1 |
| Weaver, JL | 1 |
| Benz, RD | 1 |
| Contrera, JF | 1 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Bounds, L | 1 |
| McGrath, F | 1 |
| Taubert, M | 1 |
| Karapetiantz, P | 2 |
| Audeh, B | 1 |
| Lillo-Le Louët, A | 2 |
| Bousquet, C | 2 |
| Auffret, M | 1 |
| Rolland, B | 1 |
| Béhal, H | 1 |
| Labreuche, J | 1 |
| Jouanjus, E | 1 |
| Bordet, R | 1 |
| Gautier, S | 1 |
| Borrini, L | 1 |
| Bensmail, D | 1 |
| Thiebaut, JB | 1 |
| Hugeron, C | 1 |
| Rech, C | 1 |
| Jourdan, C | 1 |
| Lumsden, DE | 1 |
| Kaminska, M | 1 |
| Tomlin, S | 1 |
| Lin, JP | 1 |
| McAllen, KJ | 1 |
| Schwartz, DR | 1 |
| El-Husseini, A | 1 |
| Sabucedo, A | 1 |
| Lamarche, J | 1 |
| Courville, C | 1 |
| Peguero, A | 1 |
| Block, F | 1 |
| Dafotakis, M | 1 |
2 reviews available for baclofen and Adverse Drug Event
| Article | Year |
|---|---|
Adverse drug reactions resulting in hyperthermia in the intensive care unit.
Topics: Baclofen; Critical Care; Drug-Related Side Effects and Adverse Reactions; Fever; Humans; Intensive C | 2010 |
[Drug-induced seizures].
Topics: Analgesics, Opioid; Anesthetics; Anti-Bacterial Agents; Anticonvulsants; Antidepressive Agents; Anti | 2013 |
10 other studies available for baclofen and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Hypercalcaemia to hypocalcaemia: tetany as a side effect of intravenous bisphosphonate treatment.
Topics: Baclofen; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypercalc | 2022 |
Signal Detection for Baclofen in Web Forums: A Preliminary Study.
Topics: Adverse Drug Reaction Reporting Systems; Baclofen; Databases, Factual; Drug-Related Side Effects and | 2018 |
[Informativity of French web forums for the evaluation of side effects of baclofen].
Topics: Adverse Drug Reaction Reporting Systems; Baclofen; Data Collection; Drug Utilization Review; Drug-Re | 2019 |
A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alcoholism; Baclofen; Data Mining; Databases, | 2019 |
Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
Topics: Adolescent; Adult; Age Distribution; Aged; Baclofen; Cerebral Palsy; Dose-Response Relationship, Dru | 2014 |
Medication use in childhood dystonia.
Topics: Adolescent; Antiparkinson Agents; Baclofen; Child; Chloral Hydrate; Cohort Studies; Diazepam; Drug-R | 2016 |
Baclofen toxicity in patients with advanced nephropathy: proposal for new labeling.
Topics: Administration, Oral; Aged; Baclofen; Drug Labeling; Drug-Related Side Effects and Adverse Reactions | 2011 |